Pages that link to "Q48122775"

The following pages link to Localization of striatal and nigral tachykinin receptors in the rat. (Q48122775):

Displaying 23 items.

• Opinion: NK3 receptor antagonists: the next generation of antipsychotics? (Q28286127) (← links)
• Modulation of cardiac activity by tachykinins in the rat substantia nigra (Q28366066) (← links)
• Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 – 2010) (Q34171734) (← links)
• Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors (Q34588695) (← links)
• In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia (Q34668685) (← links)
• Characterization of nuclear neurokinin 3 receptor expression in rat brain (Q35456037) (← links)
• Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae (Q41173089) (← links)
• Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study (Q42275533) (← links)
• Substance P depolarizes striatal projection neurons and facilitates their glutamatergic inputs (Q42525242) (← links)
• Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol. (Q46404900) (← links)
• Spatial distribution of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon (Q46619147) (← links)
• Neuropeptides in the immunomodulation: Substance p-induced stimulation of immune response in mice (Q47937568) (← links)
• Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study (Q48191396) (← links)
• Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig. (Q48333601) (← links)
• Characterization of the mechanism of action of tachykinins in rat striatal cholinergic interneurons (Q48382944) (← links)
• Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions (Q48527011) (← links)
• Regional decreases in NK-3, but not NK-1 tachykinin receptor binding in dystonic hamster (dt(sz)) brains (Q48573705) (← links)
• Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study (Q48702539) (← links)
• Expression of tachykinin NK2 receptor mRNA in human brain (Q48921759) (← links)
• Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits. (Q50086799) (← links)
• Tachykinins increase [3H]acetylcholine release in mouse striatum through multiple receptor subtypes (Q51420204) (← links)
• Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats (Q73320609) (← links)
• NK-3 receptors are expressed on mouse striatal gamma-aminobutyric acid-ergic interneurones and evoke [(3)H] gamma-aminobutyric acid release (Q73689463) (← links)